DISTINGUISHED ACHIEVEMENT AWARD
The ISBSTP Distinguished Achievement Award is presented to a member of the ISBSTP Society who has made significant achievements and contributions to the field of bone and soft tissue pathology and is recognized for leadership in this subdiscipline. The purpose of this award is to recognize a member of the Society who has attained extraordinary distinction and accomplishment in the field of bone and/or soft tissue pathology and whose achievements have brought benefit to the practice and care of patients with bone or soft tissue disease processes. This award is not intended to recognize lifetime achievement or longevity.
The pathology community lost one of the world’s foremost surgical pathologists, on July 28, 2024. Dr. Fletcher passed away at the young age of 66 years.
Born on March 13, 1958, in Huddersfield, England, Dr. Fletcher earned his Bachelor of Medicine and Bachelor in Surgery from St. Thomas’s Hospital Medical School in London in 1981. He completed residency training in Histopathology at St. Thomas’s Hospital. He earned a Doctorate of Medicine by research thesis from the University of London in 1991. His research helped debunk the notion of pleomorphic malignant fibrous histiocytoma.
During his career, Dr. Fletcher published nearly 600 journal articles, over 150 books, book chapters, and review articles.
While contributing to an incredible service load, including 5000 consultations annually, he chaired the WHO Working Group for the Classification of Tumours of Soft Tissue and Bone, served on 15 journal editorial boards, and held presidential terms at the Association of Directors of Anatomic and Surgical Pathology, the IAP, the Arthur Purdy Stout Society, the International Society of Bone and Soft Tissue Pathology, and USCAP. He boldly challenged conventional wisdom, forever changing tumor classification.
Yet, despite his innumerable contributions to the clinical arena, he will be best remembered by most of us as an incredibly generous and humble mentor, who truly cared about our individual wellbeing and future.
2025
Christopher D.M. Fletcher, MD, FRCPATH

A native of Lynn, Massachusetts, Dr. Weiss earned her A.B from Wellesley College and her M.D. from the Johns Hopkins School of Medicine. Following housestaff training at the Johns Hopkins Hospital and a brief tenure on the faculty, she joined the staff of the Armed Forces Institute of Pathology (AFIP), eventually becoming the Chair of the Department of Soft Tissue Pathology. During those 13 formative years at the AFIP, she co-authored with Franz Enzinger the now iconic textbook, Soft Tissue Tumors, now in its 6th edition. Subsequent academic appointments included the A. J. French Professor and Director of Anatomic Pathology at the University of Michigan and Professor and Vice Chair of Pathology at Emory University. In addition, she served as the Associate Dean for Faculty Affairs at the Emory University School of Medicine.
Over her career she has published extensively and lectured widely on all aspects of soft tissue tumors. She is known especially for her work on prognostic factors in undifferentiated pleomorphic sarcoma (formerly malignant fibrous histiocytoma), dedifferentiation in liposarcoma, and borderline vascular tumors (hemangioendothelioma). She and her co-workers are also credited with the first description of numerous new entities including: epithelioid hemangioendothelioma, spindle cell hemangioma (formerly spindle cell hemangioendothelioma), giant cell fibroblastoma, ossifying fibromyxoid tumor, epithelioid sarcoma-like hemangioendothelioma, pleomorphic hyalinizing angiectatic tumor, ischemic fasciitis, and inflammatory myxohyaline tumor (myxoinflammatory fibroblastic sarcoma), She has given generously of her time in many key leadership positions including Chair of the World Health Organization Committee for the Classification of Soft Tissue Tumors, President of International Society of Bone and Soft Tissue Tumors and President of the American Board of Pathology. Her honors include: Phi Beta Kappa, Alpha Omega Alpha, Alumnae Achievement Award (Wellesley College), the Society of Scholars (Johns Hopkins University) and 2014 Harvey Goldman Master Teacher and Mentoring Award (USCAP).
2015
Sharon W. Weiss

DISTINGUISHED ACHIEVEMENT AWARD SELECTION PROCESS
Description and Eligibility The ISBSTP Distinguished Achievement Award is presented to a member of the ISBSTP Society who has made significant achievements and contributions to the field of bone and soft tissue pathology and is recognized for leadership in this sub-discipline. The purpose of this award is to recognize a member of the Society who has attained extraordinary distinction and accomplishment in the field of bone and/or soft tissue pathology and whose achievements have brought benefit to the practice and care of patients with bone or soft tissue disease processes. This award is not intended to recognize lifetime achievement or longevity.
Frequency of Award A Distinguished Achievement Award will be bestowed annually at the discretion of the Awards Committee.
Nature of the Award The recipient will receive an award plaque and a cash gift from the ISBSTP Award, Scholarship and Education Fund.
Nomination Procedure Award nominations will be submitted by the Awards Committee to the Executive Committee for selection. The selection will be made by the Executive Committee based on the criteria as listed above. Particular attention will be given to the individual’s impact on the profession.
The Awards Committee must submit nominations to the Executive Committee by July 1st to enable inclusion within the Scientific Program.
Award Presentation Ceremony Presentation of the award will be made by the ISBSTP President at the annual meeting traditionally held in late February or March as a companion meeting to the United States and Canadian Academy of Pathology annual meeting.